Yi‐Ching Wang
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- DNA Repair Mechanisms
- Histone Deacetylase Inhibitors Research
Papers in
-
- Epigenetics and DNA Methylation 33
- RNA modifications and cancer 25
- Cancer-related gene regulation 16
- Histone Deacetylase Inhibitors Research 13
- Ubiquitin and proteasome pathways 11
- DNA Repair Mechanisms 9
- Oncology 30
- Cancer-related Molecular Pathways 17
- Co-authors
- Han‐Shui Hsu (31 shared papers)Jayu Jen (8 shared papers)Ruo-Kai Lin (11 shared papers)Ruo‐Chia Tseng (15 shared papers)Yen-An Tang (14 shared papers)Chih‐Yi Chen (10 shared papers)Hong‐Tai Tzeng (7 shared papers)Wu‐Wei Lai (21 shared papers)
- Journals
- Journal of Biomedical Science (14 papers)PLoS ONE (7 papers)Lung Cancer (7 papers)International Journal of Cancer (6 papers)Clinical Cancer Research (6 papers)
- Partner nations
- TaiwanUnited StatesUnited Kingdom
In The Last Decade
Yi‐Ching Wang
182 papers receiving 7.0k citations
Yi‐Ching Wang's Hit Papers
Peers
Comparison fields: 5 of 187
- Cancer Research 1.4k
- Molecular Biology 4.2k
- Oncology 1.2k
- Structural Biology 69
- Cell Biology 404
Countries citing papers authored by Yi‐Ching Wang
This map shows the geographic impact of Yi‐Ching Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Ching Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Ching Wang more than expected).
Fields of papers citing papers by Yi‐Ching Wang
This network shows the impact of papers produced by Yi‐Ching Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Ching Wang. The network helps show where Yi‐Ching Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi‐Ching Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 285 | |
| 2 | 2006 | 209 | |
| 3 | An innovative NRF2 nano-modulator induces lung cancer ferroptosis and elicits an immunostimulatory tumor microenvironment Hit paper breakdown → | 2021 | 207 |
| 4 | 2017 | 189 | |
| 5 | 2010 | 182 | |
| 6 | 2010 | 172 | |
| 7 | p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. | 1999 | 158 |
| 8 | 2016 | 144 | |
| 9 | 1993 | 143 | |
| 10 | 2007 | 129 | |
| 11 | 2003 | 125 | |
| 12 | 2011 | 118 | |
| 13 | 2014 | 118 | |
| 14 | 2010 | 114 | |
| 15 | 2007 | 109 | |
| 16 | 2005 | 105 | |
| 17 | 2001 | 101 | |
| 18 | 2019 | 99 | |
| 19 | 2010 | 93 | |
| 20 | 2021 | 90 |
About Yi‐Ching Wang
Yi‐Ching Wang is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Genetics, having authored 186 papers that have together received 7.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (33 papers), RNA modifications and cancer (25 papers), Cancer-related Molecular Pathways (17 papers), Cancer-related gene regulation (16 papers), Histone Deacetylase Inhibitors Research (13 papers), Ubiquitin and proteasome pathways (11 papers), Metal-Organic Frameworks: Synthesis and Applications (10 papers) and DNA Repair Mechanisms (9 papers). The work is most often cited by research in Cancer Research (1.4k citations), Molecular Biology (4.2k citations), Oncology (1.2k citations), Structural Biology (69 citations) and Cell Biology (404 citations). Yi‐Ching Wang has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Han‐Shui Hsu, Jayu Jen, Ruo-Kai Lin, Ruo‐Chia Tseng, Yen-An Tang, Chih‐Yi Chen, Hong‐Tai Tzeng, Wu‐Wei Lai, Jer-Wei Chang and Pinpin Lin. Their work appears in journals such as Journal of Biomedical Science, PLoS ONE, Lung Cancer, International Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.